| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1. Admissions/ Management Information | |||||||||||||||||||||||||||||||||||||||
2 | Title of the new programme – including any year abroad/ in industry variants (which are to be styled as in the following example: BA in History (with a year abroad)/ (with a year in industry)/ (with a placement year)/ (with a year in enterprise), see also sections 9 and 10). See guidance on programme titles in Appendix V: | |||||||||||||||||||||||||||||||||||||||
3 | https://www.york.ac.uk/media/staffhome/learningandteaching/documents/policies/Framework%20for%20Programme%20Design%20-%20UG.pdf | |||||||||||||||||||||||||||||||||||||||
4 | Independent and Supplementary Prescribing for Non- Medical Prescribers: Nurses, Midwives, Pharmacists and Allied Health Professionals (AHP’s) | |||||||||||||||||||||||||||||||||||||||
5 | Level of qualification | |||||||||||||||||||||||||||||||||||||||
6 | Please select: | Level 6 | ||||||||||||||||||||||||||||||||||||||
7 | Please indicate if the programme is offered with any year abroad / in industry variants NB: This does not include the opportunity for students to take the Careers and Placements 'With Placement Year' (see section 10). | Year in Industry Please select Y/N | No | |||||||||||||||||||||||||||||||||||||
8 | Year Abroad Please select Y/N | No | ||||||||||||||||||||||||||||||||||||||
9 | This document applies to students who commenced the programme(s) in: | September 2020 | ||||||||||||||||||||||||||||||||||||||
10 | Awarding institution | Teaching institution | ||||||||||||||||||||||||||||||||||||||
11 | University of York | University of York | ||||||||||||||||||||||||||||||||||||||
12 | Department(s): Where more than one department is involved, indicate the lead department | Board of Studies | ||||||||||||||||||||||||||||||||||||||
13 | Lead Department | Health Sciences | Health Sciences | |||||||||||||||||||||||||||||||||||||
14 | Other contributing Departments: | |||||||||||||||||||||||||||||||||||||||
15 | Interim awards available Interim awards available on undergraduate programmes (subject to programme regulations) will normally be: Certificate of Higher Education (Level 4/Certificate), Diploma of Higher Education (Level 5/Intermediate), Ordinary Degree and in the case of Integrated Masters the Bachelors with honours. Please specify any proposed exceptions to this norm. | |||||||||||||||||||||||||||||||||||||||
16 | N/A | |||||||||||||||||||||||||||||||||||||||
17 | UCAS code | Route code (existing programmes only) | ||||||||||||||||||||||||||||||||||||||
18 | Admission to the programme is by direct application only. | |||||||||||||||||||||||||||||||||||||||
19 | Admissions criteria | |||||||||||||||||||||||||||||||||||||||
20 | Due to Professional, Regulatory Statutory Bodies (PRSB), different admissions criteria are used to achieve ensure the student is compliant with the relevant PRSB. Students will be: • Registered on the relevant professional register (Nursing and Midwifery Council (NMC) , General Pharmaceutical Council (GPhC), Health and Care Professions Council (HCPC) • Evidence of academic ability, previous study at level 5 or 6 or assessed written piece • Have at least 2 years appropriate patient orientated experience in a hospital, community or primary care setting following their pre-registration year (pharmacists); • Have at least 3 years’ post qualification experience (AHP’s) and working as an adavnced practitioner (or equivalent) • Have an approved Practice Assessor (Designated Prescribing Practitioner (DPP) who is a registered healthcare professional and meets the Royal Pharmacuetical Competency Framework for Designated Prescribing Practitioners (2019) • Have identified an area of clinical practice in which to develop their prescribing skills and have up to date clinical, pharmacological and pharmaceutical knowledge relevant to their intended area of prescribing practice (pharmacists). • Have written confirmation of employer support | |||||||||||||||||||||||||||||||||||||||
21 | Length and status of the programme(s) and mode(s) of study | |||||||||||||||||||||||||||||||||||||||
22 | Programme | Length (years) | Status (full-time/part-time) Please select | Start dates/months (if applicable – for programmes that have multiple intakes or start dates that differ from the usual academic year) | Mode | |||||||||||||||||||||||||||||||||||
23 | ||||||||||||||||||||||||||||||||||||||||
24 | Face-to-face, campus-based | Distance learning | Other | |||||||||||||||||||||||||||||||||||||
25 | Independent and Supplementary prescribing for non-medical prescribers (Nurses, Midwives Allied Health Professionals Level 6 | 0.5 | Part-time | September, January & March | Please select Y/N | Yes | Please select Y/N | No | ||||||||||||||||||||||||||||||||
26 | Language(s) of study | |||||||||||||||||||||||||||||||||||||||
27 | English | |||||||||||||||||||||||||||||||||||||||
28 | Language(s) of assessment | |||||||||||||||||||||||||||||||||||||||
29 | English | |||||||||||||||||||||||||||||||||||||||
30 | 2. Programme accreditation by Professional, Statutory or Regulatory Bodies (PSRB) | |||||||||||||||||||||||||||||||||||||||
31 | 2.a. Is the programme recognised or accredited by a PSRB | |||||||||||||||||||||||||||||||||||||||
32 | Please Select Y/N: | Yes | if No move to section 3 if Yes complete the following questions | |||||||||||||||||||||||||||||||||||||
33 | 2.b. Name of PSRB | |||||||||||||||||||||||||||||||||||||||
34 | Nursing and Midwifery Council (NMC), Health and Care Professions Council (HCPC), General Pharmaceutical Council (GPhC) | |||||||||||||||||||||||||||||||||||||||
35 | 2.c. Please provide details of any approval / accreditation event needed, including: timescales, the nature of the event, central support / information required: Please also specify whether any accreditation arrangement will require renewal during the expected period of study of the cohort of students covered by this document; if such an event will be required, please state what the implications are for students who are already enrolled should accreditation not be renewed. | |||||||||||||||||||||||||||||||||||||||
36 | The new NMC standards for Prescribing Programmes were published in May 2018. An application has been made for joint approval of the Independent and Supplementary Prescribing programme for Non-Medical Prescribers to be delivered under these standards. The Gateway approval is scheduled for March 2020. | |||||||||||||||||||||||||||||||||||||||
37 | 2.d. Does/ will approval or recognition require exceptions to University rules/practices? Please select Y/N | Yes | if Yes, provide details | |||||||||||||||||||||||||||||||||||||
38 | In accordance with the Nursing Midwifery Council Standards for Prescribing programmes (2018) Students must achieve a minimum of 80% in order to pass an unseen exam focused on pharmacology and 100% on a numeracy exam . These are therefore not used in the final mark awarded to the programme. | |||||||||||||||||||||||||||||||||||||||
39 | 2.e. Any additional information (e.g. student attainment required to achieve accreditation) that are required by the PSRB should be recorded here | |||||||||||||||||||||||||||||||||||||||
40 | The Nursing and Midwifery Council's Standards for Prescribing Programmes (2018) stipulate that those undertaking the programme must demonstrate achievement of the Royal Pharmaceutical Society's (2016) A Competency Framework for all Prescribers. These are a set of competencies which speak to all prescribers from any professional health care discipline with prescriptive authority (i.e. Registered Nurses, Pharmacists, Midwives, Physiotherapists etc.). The assessment of these competencies takes place in the student's workplace/ placement learning undertaken by their Designated Prescribing Practitioner (DPP). The term DPP describes an Independent Prescriber with at least the equivalent qualification of the one being studied by the student as well as with appropriate understanding and experience of supporting and assessing students in the practice environment. The assessment of achievement of the RPS competencies is undertaken by the Designated Prescribing Practitioner acting as Practice Assessor (NMC). The student's practice assessment is informed by discussions with a Practice Supervisor and confirmed by an Academic Assessor, a member of the programem team with the relevant qualifications and experience. In addition the Nursing and Midwifery Council Standards for prescribing programmes (2018) stipulate that students must achieve 80% in an unseen examination related to pharmacology knowledge as well as a numeracy examination which must be passed with 100%. | |||||||||||||||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||||||||||||||||
42 | Are there any additional requirements of accrediting bodies or PSRB or pre-requisite professional experience needed to study this programme? | |||||||||||||||||||||||||||||||||||||||
43 | Please Select Y/N: | Yes | if Yes, provide details | |||||||||||||||||||||||||||||||||||||
44 | Applicants who are registered with the NMC will have to have been registered for a minimum of 2 years and evidence that they are capable of safe and effective practice at a level of proficiency appropriate to the programme to be undertaken and their intended area of prescribing practice in the following areas: Clinical/health assessment, diagnostics/care management and planning and evaluation of care. | |||||||||||||||||||||||||||||||||||||||
45 | 4. Programme leadership and programme team | |||||||||||||||||||||||||||||||||||||||
46 | 4.a. Please name the programme leader for the year to which the programme design applies and any key members of staff responsible for designing, maintaining and overseeing the programme. NB: If the proposal is for a combined programme the name of the Programme Leader (based in the Lead Department) and the Associate Programme Leader(s) from the Partner Department(s) should be provided. | |||||||||||||||||||||||||||||||||||||||
47 | Mike Kitching(Programme Lead), Ann Bellerby (Deputy Programme Lead), Jodie Coulson, Sally Porter, Jo Poskitt | |||||||||||||||||||||||||||||||||||||||
48 | 4.b. How are wider stakeholders such as students/ alumni, professional bodies and employers involved in the design of the programme and in ongoing reflection on its effectiveness? | |||||||||||||||||||||||||||||||||||||||
49 | The programme is designed to enable the student to apply appropriate subject knowledge to clinical practice in order to demonstrate the RPS competencies which have been adopted by the NMC. As an integral part of the curriculum development and approval process, stakeholder events, involving students, service users and carers and practice partners have been held where their views have been actively sought on the module design, and the teaching, learning and assessment strategy. Stakeholders will continue to be able to reflect upon the effectiveness of the programme through student evaluations, service user and carer forum meetings and Programme team meetings with practice partners. | |||||||||||||||||||||||||||||||||||||||
50 | 5. Purpose and learning outcomes of the programme | |||||||||||||||||||||||||||||||||||||||
51 | 5.a. Statement of purpose for applicants to the programme Please express succinctly the overall aims of the programme as an applicant facing statement for a prospectus or website. This should clarify to a prospective student why they should choose this programme, what it will provide to them and what benefits they will gain from completing it. | |||||||||||||||||||||||||||||||||||||||
52 | This programme aims to prepare Registered Nurses, Midwives, Paramedics, Physiotherapists, Dietitians and Pharmacists who meet the relevant PRSB entry requirements to prescribe safely, appropriately and cost effectively as an independent / supplementary prescriber. It will enable those who are successful to contribute to enhance patient care, benefiting the patient, the professions and the healthcare service. Learning in both theory and practice enables the development of a professional who is a proficient prescriber with the skills to continue their professional development. | |||||||||||||||||||||||||||||||||||||||
53 | 5.b.Programme Learning Outcomes Please provide six to eight statements of what a graduate of the programme can be expected to do. Taken together, these outcomes should capture the distinctive features of the programme. They should also be outcomes for which progressive achievement through the course of the programme can be articulated, and which will therefore be reflected in the design of the whole programme. | |||||||||||||||||||||||||||||||||||||||
54 | PLO | On successful completion of the programme, graduates will be able to: | ||||||||||||||||||||||||||||||||||||||
55 | 1 | Demonstrate competence in undertaking person-centered consultations, using diagnostic skills as required, leading to a prescribing decision. | ||||||||||||||||||||||||||||||||||||||
56 | 2 | Apply knowledge of pharmacology and medicines optimisation to prescribing practice. | ||||||||||||||||||||||||||||||||||||||
57 | 3 | Critically review the local, national and global influences on prescribing practice. | ||||||||||||||||||||||||||||||||||||||
58 | 4 | Plan safe and effective management, informed by a systematic understanding of the evidence base underpinning prescribing practice. | ||||||||||||||||||||||||||||||||||||||
59 | 5 | Critically appraise sources of information which informs and empowers the individual within shared decision making. | ||||||||||||||||||||||||||||||||||||||
60 | 6 | Demonstrate a critical appreciation of ethical, legal and professional frameworks which underpin prescribing practice. | ||||||||||||||||||||||||||||||||||||||
61 | 7 | Apply appropriate quality assurance tools, including audit, to improve prescribing practice. | ||||||||||||||||||||||||||||||||||||||
62 | 8 | Identify and evaluate the skills of colleagues and work collaboratively as part of a multidisciplinary team to enhance prescribing practice. | ||||||||||||||||||||||||||||||||||||||
63 | 5.c. Programme Learning Outcome for year in industry (where applicable) For programmes which lead to the title ‘(with a year in industry)’ – typically involving an additional year – please provide either a) amended versions of some (at least one, but not necessarily all) of the standard PLOs listed above, showing how these are changed and enhanced by the additional year in industry b) an additional PLO, if and only if it is not possible to capture a key ability developed by the year in industry by alteration of the standard PLOs. (See also section 10) | |||||||||||||||||||||||||||||||||||||||
64 | N/A | |||||||||||||||||||||||||||||||||||||||
65 | 5.d. Programme Learning Outcome for year abroad programmes (where applicable) For programmes which lead to the title ‘(with a year abroad)’ – typically involving an additional year – please provide either a) amended versions of some (at least one, but not necessarily all) of the standard PLOs listed above, showing how these are changed and enhanced by the additional year abroad or b) an additional PLO, if and only if it is not possible to capture a key ability developed by the year abroad by alteration of the standard PLOs. (See also section 11) | |||||||||||||||||||||||||||||||||||||||
66 | N/A | |||||||||||||||||||||||||||||||||||||||
67 | 5.e. Explanation of the choice of Programme Learning Outcomes Please explain your rationale for choosing these PLOs in a statement that can be used for students (such as in a student handbook). Please include brief reference to: | |||||||||||||||||||||||||||||||||||||||
68 | i) Why the PLOs are considered ambitious or stretching? | |||||||||||||||||||||||||||||||||||||||
69 | Programme outcomes have been designed to both align to the Royal Pharmaceutical Society (2016) A competency framework for all prescribers (a framework adopted by all UK PRSB's) as well as enable the student to demonstrate their academic ability. The outcomes enable the student to demonstrate their competence in prescribing practice as well as demonstrate their critical thinking in a contemporary manner. | |||||||||||||||||||||||||||||||||||||||
70 | ii) The ways in which these outcomes are distinctive or particularly advantageous to the student: | |||||||||||||||||||||||||||||||||||||||
71 | These learning outcomes clearly articulate what is required to be awarded prescriber status as they are directly aligned to the Royal Pharmaceutical Society (2016) A competency framework for all prescribers . Meeting the PRSB requirements means that successful students will be able to apply for registration/annotation with their PRSB as a prescriber. | |||||||||||||||||||||||||||||||||||||||
72 | iii) How the programme learning outcomes develop students’ digital literacy and use technology-enhanced learning to achieve the discipline and pedagogic goals which support active student learning through peer/tutor interaction, collaboration and formative (self) assessment opportunities (reference could be made to such as blogging, flipped classrooms, response 'clickers' in lectures, simulations, etc). | |||||||||||||||||||||||||||||||||||||||
73 | The VLE will be used to support student learning. Embedded within the VLE will be links to additional electronic learning resources (videos) and discussion boards. An e-Portfolio (PebblePad) will be used to document learning in practice hours and achievement of the Royal Pharmaceutical Society competencies in practice. The e-portfolio will be used a medium to ensure effective communication between all personnel involved in the supervision and assessment of the NMP student. Assessment strategies will incorporate TEL through the use of presentations, in addition to VLE upload etc. Peer and tutor interaction will include the use of module discussion board, wikis and other TEL approaches. Other communication strategies incorporating TEL include online conference calls. | |||||||||||||||||||||||||||||||||||||||
74 | iv) How the PLOs support and enhance the students’ employability (for example, opportunities for students to apply their learning in a real world setting)? The programme's employability objectives should be informed by the University's Employability Strategy: | |||||||||||||||||||||||||||||||||||||||
75 | http://www.york.ac.uk/about/departments/support-and-admin/careers/staff/ | |||||||||||||||||||||||||||||||||||||||
76 | The students on the programme will already be employed. They will be undertaking the programme to enable them to extend their scope of practice. Successful completion of this programme and awarding of prescriber status by the professional body will help to enhance the student's employability. | |||||||||||||||||||||||||||||||||||||||
77 | v) Consultation with Careers The programme proposal should be discussed with Careers. Please contact your Faculty Employability Manager. Please provide details of Careers' comments and your response. | |||||||||||||||||||||||||||||||||||||||
78 | The department have an ongoing workstream with Careers. | |||||||||||||||||||||||||||||||||||||||
79 | vi) How will students who need additional support for academic and transferable skills be identified and supported by the Department? | |||||||||||||||||||||||||||||||||||||||
80 | Students with a recognised disability will be supported in accordance with University policy. All students will be encouraged to access the University resources to develop their academic skills. | |||||||||||||||||||||||||||||||||||||||
81 | vii) How is teaching informed and led by research in the department/ centre/ University? | |||||||||||||||||||||||||||||||||||||||
82 | Research is integrated into all aspects of curriculum content and delivery. The curriculum design is research informed and teaching and assessment strategies reflect this approach. Research staff from within and external to the department actively deliver and contribute to teaching sessions within the programme. | |||||||||||||||||||||||||||||||||||||||
83 | 5.f. Stage-level progression Please complete the table below, to summarise students’ progressive development towards the achievement of PLOs, in terms of the characteristics that you expect students to demonstrate at the end of each year. This summary may be particularly helpful to students and the programme team where there is a high proportion of option modules. Note: it is not expected that a position statement is written for each PLO, but this can be done if preferred (please add information in the 'individual statement' boxes). For a statement that applies across all PLOs in the stage fill in the 'Global statement' box. | |||||||||||||||||||||||||||||||||||||||
84 | Stage 0 (if your programme has a Foundation year, use the toggles to the left to show the hidden rows) | |||||||||||||||||||||||||||||||||||||||
88 | Stage 1 | |||||||||||||||||||||||||||||||||||||||
89 | On progression from the first year (Stage 1), students will be able to: | Global statement | ||||||||||||||||||||||||||||||||||||||
90 | PLO 1 | PLO 2 | PLO 3 | PLO 4 | PLO 5 | PLO 6 | PLO 7 | PLO 8 | ||||||||||||||||||||||||||||||||
91 | Individual statements | |||||||||||||||||||||||||||||||||||||||
92 | Stage 2 | |||||||||||||||||||||||||||||||||||||||
93 | On progression from the second year (Stage 2), students will be able to: | Global statement | ||||||||||||||||||||||||||||||||||||||
94 | PLO 1 | PLO 2 | PLO 3 | PLO 4 | PLO 5 | PLO 6 | PLO 7 | PLO 8 | ||||||||||||||||||||||||||||||||
95 | Individual statements | |||||||||||||||||||||||||||||||||||||||
96 | Stage 3 | |||||||||||||||||||||||||||||||||||||||
97 | (For Integrated Masters) On progression from the third year (Stage 3), students will be able to: | Global statement | ||||||||||||||||||||||||||||||||||||||
98 | PLO 1 | PLO 2 | PLO 3 | PLO 4 | PLO 5 | PLO 6 | PLO 7 | PLO 8 | ||||||||||||||||||||||||||||||||
99 | Demonstrate competence in undertaking person-centered consultations, using diagnostic skills as required, leading to a prescribing decision. | Apply knowledge of pharmacology and medicines optimisation to prescribing practice. | Critically review the local, national and global influences on prescribing practice. | Plan safe and effective management, informed by a systematic understanding of the evidence base underpinning prescribing practice. | Critically appraise sources of information which informs and empowers the individual within shared decision making. | Demonstrate a critical appreciation of ethical, legal and professional frameworks which underpin prescribing practice. | Apply appropriate quality assurance tools, including audit, to improve prescribing practice. | Identify and evaluate the skills of colleagues and work collaboratively as part of a multidisciplinary team to enhance prescribing practice. | ||||||||||||||||||||||||||||||||
100 | 5.g. Other features of the programme | |||||||||||||||||||||||||||||||||||||||
101 | i) Distance Learning Does the programme involve distance learning: | |||||||||||||||||||||||||||||||||||||||
102 | Please Select Y/N: | No | if Yes, you are required to submit to Teaching Committee: | |||||||||||||||||||||||||||||||||||||
103 | Checklist for Distance Learning Programmes | |||||||||||||||||||||||||||||||||||||||